Neuropath Limited
Unaudited Financial Statements
For the year ended 28 February 2025
Pages for Filing with Registrar
Company Registration No. 08884885 (England and Wales)
Neuropath Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 5
Neuropath Limited
Balance Sheet
As at 28 February 2025
28 February 2025
Page 1
2025
2024
Notes
£
£
£
£
Current assets
Debtors
4
22,272
18,200
Cash at bank and in hand
15,288
15,847
37,560
34,047
Creditors: amounts falling due within one year
5
(13,600)
(15,117)
Net current assets
23,960
18,930
Capital and reserves
Called up share capital
6
100
100
Profit and loss reserves
23,860
18,830
Total equity
23,960
18,930

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 9 November 2025 and are signed on its behalf by:
T S Jacques
Director
Company Registration No. 08884885
Neuropath Limited
Notes to the Financial Statements
For the year ended 28 February 2025
Page 2
1
Accounting policies
Company information

Neuropath Limited is a private company limited by shares incorporated in England and Wales. The registered office is 4 Victoria Square, St Albans, Hertfordshire, AL1 3TF.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recover ed.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
3 Years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

Neuropath Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
1
Accounting policies
(Continued)
Page 3
1.5
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Neuropath Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
1
Accounting policies
(Continued)
Page 4
1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Directors
2
2
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 29 February 2024 and 28 February 2025
5,398
Depreciation and impairment
At 29 February 2024 and 28 February 2025
5,398
Carrying amount
At 28 February 2025
-
0
At 28 February 2024
-
0
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
22,272
18,200
Neuropath Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2025
4
Debtors
(Continued)
Page 5
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
5,402
1,670
Other taxation and social security
4,198
9,447
Accruals and deferred income
4,000
4,000
13,600
15,117
6
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
100
100
100
100
7
Controlling party

The directors are of the opinion that the company has no one controlling party.

2025-02-28 2024-02-29 false false false 18 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity T S Jacques C M Jacques 08884885 2024-02-29 2025-02-28 08884885 2025-02-28 08884885 2024-02-28 08884885 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 08884885 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-28 08884885 core:ShareCapital 2025-02-28 08884885 core:ShareCapital 2024-02-28 08884885 core:RetainedEarningsAccumulatedLosses 2025-02-28 08884885 core:RetainedEarningsAccumulatedLosses 2024-02-28 08884885 core:ShareCapitalOrdinaryShareClass1 2025-02-28 08884885 core:ShareCapitalOrdinaryShareClass1 2024-02-28 08884885 bus:Director1 2024-02-29 2025-02-28 08884885 core:ComputerEquipment 2024-02-29 2025-02-28 08884885 2023-03-01 2024-02-28 08884885 core:OtherPropertyPlantEquipment 2024-02-28 08884885 core:OtherPropertyPlantEquipment 2025-02-28 08884885 core:OtherPropertyPlantEquipment 2024-02-28 08884885 core:CurrentFinancialInstruments 2025-02-28 08884885 core:CurrentFinancialInstruments 2024-02-28 08884885 bus:OrdinaryShareClass1 2024-02-29 2025-02-28 08884885 bus:OrdinaryShareClass1 2025-02-28 08884885 bus:OrdinaryShareClass1 2024-02-28 08884885 bus:PrivateLimitedCompanyLtd 2024-02-29 2025-02-28 08884885 bus:SmallCompaniesRegimeForAccounts 2024-02-29 2025-02-28 08884885 bus:FRS102 2024-02-29 2025-02-28 08884885 bus:AuditExemptWithAccountantsReport 2024-02-29 2025-02-28 08884885 bus:Director2 2024-02-29 2025-02-28 08884885 bus:FullAccounts 2024-02-29 2025-02-28 xbrli:pure xbrli:shares iso4217:GBP